Scienture Holdings, Inc.

Scienture Holdings, Inc.

Pharmaceutical Retailers • Healthcare • Tampa, FL, United States • SCNX (NCM)

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. The Scienture segment researches and develops branded pharmaceutical products. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is based in Tampa, Florida.

800 261 0281 6308 Benjamin Rd, Tampa, FL 33634, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Scienture Holdings Inc. (SCNX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
StocksToTrade • Jan 3
Scienture (NASDAQ: SCNX) launches Arbli, FDA-approved liquid losartan; revenue hits $590K - Stock Titan
Stock Titan • Nov 13
Scienture Holdings stockholders approve reverse split and equity plan expansion - Investing.com
Investing.com • Nov 14
Why Is Scienture Stock Gaining Today? - Scienture Holdings (NASDAQ:SCNX) - Benzinga
Benzinga • Dec 10
EXCLUSIVE: Scienture Delivers Q3 Revenue Jump With Arbli Sales And Debt Reduction - Yahoo Finance
Yahoo Finance • Nov 13

Other Pharmaceutical Retailers Companies

View All →
Sugi Holdings Co., Ltd./ADR logo Sugi Holdings Co. Ltd.
$2.95B market cap
High Tide Inc. logo High Tide Inc.
$242.2M market cap
PETMED EXPRESS INC logo Petmed Express Inc.
$74.2M market cap
Wellgistics Health, Inc. logo Wellgistics Health, Inc.
$41.3M market cap
BLUM HOLDINGS, INC. logo BLUM Holdings, Inc.
$15.6M market cap
PINEAPPLE, INC. logo Pineapple, Inc.
$9.5M market cap

Frequently Asked Questions

Has Scienture Holdings, Inc. had layoffs?
No layoff events have been recorded for Scienture Holdings, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Scienture Holdings, Inc. have?
Scienture Holdings, Inc. has approximately 14 employees.
What industry is Scienture Holdings, Inc. in?
Scienture Holdings, Inc. operates in the Pharmaceutical Retailers industry, within the Healthcare sector.
Is Scienture Holdings, Inc. a publicly traded company?
Yes, Scienture Holdings, Inc. is publicly traded under the ticker symbol SCNX on the NCM. The company has a market capitalization of approximately $0.02 billion.
Where is Scienture Holdings, Inc. headquartered?
Scienture Holdings, Inc. is headquartered in Tampa, FL, United States at 6308 Benjamin Rd, Tampa, FL 33634, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.